ESC/EASD Joint Guidelines on Diabetes and Cardiovascular Diseases

被引:0
|
作者
Motz, Wolfgang [1 ]
Doerr, Rolf [2 ]
机构
[1] Klin Grp Dr Guth GmbH & Co KG, Klinikum Karlsburg, D-17495 Karlsburg, Germany
[2] Akad Lehrpraxisklin TU, Praxisklin Herz & Gefasse Kardiol Angiol Radiol N, Dresden, Germany
关键词
Diabetes mellitus; Prediabetes; Cardiovascular diseases; Coronary heart disease; Coronary artery disease equivalent; Risk factors; Coronary revascularization; CORONARY-HEART-DISEASE; DRUG-ELUTING STENTS; ELEVATION MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; BLOOD-PRESSURE; CLINICAL-OUTCOMES; GLUCOSE-TOLERANCE; RISK-FACTORS; FOLLOW-UP; MELLITUS;
D O I
10.1007/s00059-009-3203-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ESC/EASD (European Society of Cardiology/European Association for the Study of Diabetes) joint Guidelines on diabetes, pre-diabetes, and cardiovascular diseases have, for the first time, addressed diabetes mellitus and cardiovascular diseases (CVD) as a pathophysiological entity in Europe. Based on these guidelines, diabetes mellitus is regarded from the outset to be a cardiovascular disease, whose life-threatening complications myocardial infarction and stroke can only be avoided by an interdisciplinary concerted action. The most important information of these guidelines for the interdisciplinary cooperation of primary-care physicians, diabetologists and cardiologists are the postulations that patients with the main diagnosis diabetes mellitus with or without known CVD should, at regular intervals, be referred to a cardiologist, and patients with the main diagnosis CVD with or without diabetes mellitus should, at regular intervals, be referred to a diabetologist. Of fundamental importance is the prevention of diabetes and CVD by a comprehensive lifestyle modification including smoking cessation, regular physical activity and weight control, flanked by an evidence-based drug therapy. Within the framework of a multimodal risk management, an optimal antihypertensive therapy of a concomitant elevated blood pressure; a statin therapy in case of elevated LDL cholesterol or regardless of an elevated LDL in proven CVD; ACE inhibitors, angiotensin II receptor blockers, or beta-blockers in case of heart failure; and an anticoagulant therapy for the prevention of cardioembolic stroke in patients with atrial fibrillation all have class I recommendations. Concerning the preferred coronary revascularization procedure in diabetics, today no rigid general recommendation can be given in favor of or against coronary bypass surgery, or in favor of or against percutaneous coronary intervention. The decision for a specific revascularization procedure should, in any case, be based on a detailed analysis of the individual coronary anatomy.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [31] Could mitochondrial efficiency explain the susceptibility to adiposity, metabolic syndrome, diabetes and cardiovascular diseases in South Asian populations?
    Bhopal, Raj S.
    Rafnsson, Snorri B.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2009, 38 (04) : 1072 - 1081
  • [32] Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
    Goldberg, Ronald B.
    Orchard, Trevor J.
    Crandall, Jill P.
    Boyko, Edward J.
    Budoff, Matthew
    Dabelea, Dana
    Gadde, Kishore M.
    Knowler, William C.
    Lee, Christine G.
    Nathan, David M.
    Watson, Karol
    Temprosa, Marinella
    CIRCULATION, 2022, 145 (22) : 1632 - 1641
  • [33] 2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept
    Volpe, Massimo
    Tocci, Giuliano
    JOURNAL OF HYPERTENSION, 2009, 27 : S3 - S11
  • [34] Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases
    Larsson, Susanna C.
    Wallin, Alice
    Hakansson, Niclas
    Stackelberg, Otto
    Back, Magnus
    Wolk, Alicja
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 262 : 66 - 70
  • [35] Negative emotions associated with cardiovascular diseases
    Balog Piroska
    ORVOSI HETILAP, 2018, 159 (48) : 2005 - 2010
  • [36] Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population
    Cebrian-Cuenca, Ana M.
    Mata-Cases, Manel
    Franch-Nadal, Josep
    Mauricio, Didac
    Orozco-Beltran, Domingo
    Consuegra-Sanchez, Luciano
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (18) : E32 - E34
  • [37] Cardiovascular Diseases and Diabetes as Economic and Developmental Challenges in Africa
    Kengne, Andre Pascal
    Mchiza, Zandile June-Rose
    Amoah, Albert George Baidoe
    Mbanya, Jean-Claude
    PROGRESS IN CARDIOVASCULAR DISEASES, 2013, 56 (03) : 302 - 313
  • [38] The Burden of Cardiovascular Disease in Patients With Diabetes
    Hudspeth, Brooke
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (13) : S268 - S272
  • [39] Cardiovascular Diseases after Kidney Transplantation in Korea
    Jeong, Jong Cheol
    Ro, Han
    Hwang, Young-Hwan
    Lee, Han Kyu
    Ha, Jongwon
    Ahn, Curie
    Yang, Jaeseok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (11) : 1589 - 1594
  • [40] Red meat consumption, cardiovascular diseases, and diabetes: a systematic review and meta-analysis
    Shi, Wenming
    Huang, Xin
    Schooling, C. Mary
    Zhao, Jie, V
    EUROPEAN HEART JOURNAL, 2023, 44 (28) : 2626 - +